Creative Medical Technology Holdings Announces Agreement with Greenstone Biosciences, Inc. for Development of a Next Generation iPSC Pipeline for its ImmCelz® Immunotherapy Platform
We are thrilled to announced our project iPScelz with Creative Medical Technology Holdings (Nasdaq: $CELZ) in creating a cutting edge iPSC platform!